Literature DB >> 35494200

46XX Testicular Disorder of Sex Development.

Aasim N Maldar1, Phulrenu H Chauhan1.   

Abstract

Entities:  

Year:  2022        PMID: 35494200      PMCID: PMC9053341          DOI: 10.4103/jhrs.jhrs_19_22

Source DB:  PubMed          Journal:  J Hum Reprod Sci        ISSN: 1998-4766


× No keyword cloud information.
Dear Editor, We would like to add to the sparse literature on 46XX testicular disorder of sexual development due to the sex-determining region of Y-chromosome (SRY) translocation, wherein there are only 38 papers thus far, including the one reported by Dr. Mantravadi and Dr. Rao.[1] These patients typically seek medical attention for primary infertility or delayed puberty, while a few present in the newborn period with genital ambiguity or hypospadias.[23] Although the varying degree of gynaecomastia occurs in around 10%–30% of patients,[23] gynaecomastia as presenting complaint has not been seen in any of the reports. A 26-year-old man had presented to our clinic with the only complaint of gynaecomastia of 10 years. He had sparse facial hair growth, with a sexual maturity rating of grade three breasts bilaterally (B3), Tanner stage five pubic hair (P5), the testicular volume of 2 ml bilaterally, and stretch penile length of 9 cm. He had no issues with spontaneous erections or libido. The hormonal evaluation was suggestive of hypergonadotrophic hypogonadism, with karyotype analysis demonstrating 46XX chromosomes, and fluorescent in situ hybridisation confirming SRY gene translocation to the short arm of chromosome X (Xp). Low-volume azoospermia was reported on semen analysis. The patient was initiated on testosterone replacement therapy, and reduction mammoplasty was advised for gynaecomastia. Dr. Mantravadi and Dr. Rao have rightly emphasised the need for multi-speciality approach, including infertility expert, urologist, endocrinologist, psychiatrist and geneticist.[1] We would like to add that testosterone replacement therapy is necessary to correct hypogonadism, and for the long-term physical and sexual well-being of the patient. Furthermore, these patients are at an increased risk of gonadoblastoma;[4] therefore, regular self-examination and ultrasound of testes should be encouraged.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

Review 1.  Malignancy in disorders of sex development.

Authors:  Martin Kathrins; Thomas F Kolon
Journal:  Transl Androl Urol       Date:  2016-10

2.  Ten cases with 46,XX testicular disorder of sex development: single center experience.

Authors:  Emre Can Akinsal; Numan Baydilli; Abdullah Demirtas; Cetin Saatci; Oguz Ekmekcioglu
Journal:  Int Braz J Urol       Date:  2017 Jul-Aug       Impact factor: 1.541

Review 3.  46,XX Testicular Disorder of Sex Development (DSD): A Case Report and Systematic Review.

Authors:  Marco Terribile; Marco Stizzo; Celeste Manfredi; Carmelo Quattrone; Francesco Bottone; Dario Ranieri Giordano; Giuseppe Bellastella; Davide Arcaniolo; Marco De Sio
Journal:  Medicina (Kaunas)       Date:  2019-07-12       Impact factor: 2.430

4.  46XX Testicular Disorder of Sex Development.

Authors:  Krishna Chaitanya Mantravadi; Durga Gedela Rao
Journal:  J Hum Reprod Sci       Date:  2021-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.